Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GATA-type zinc finger protein 1 (ZGLP1) is an evolutionarily conserved transcription factor characterized by a GATA-like zinc finger domain that enables sequence-specific DNA binding and regulation of gene expression, particularly in the nucleus of cells. ZGLP1 plays a crucial role in germ cell development, notably oocyte maturation, by activating key genes required for the oogenic program and by both positively and negatively regulating transcription by RNA polymerase II. It is expressed in multiple tissues such as the gonads, heart, liver, lungs, and kidneys, and is particularly important in embryonic germ cells in females. Dysregulation of ZGLP1 may be involved in certain diseases, including reproductive disorders and potentially cancer, making it a target of interest in biomedical research and drug development. However, no drugs or specific biomarkers for patient selection have been established for ZGLP1 to date.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GATA-type zinc finger protein 1 (ZGLP1).